Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

End-stage chronic heart failure.

G Leibundgut1, Hans Peter Brunner-La Rocca

  • 1Cardiology, University Hospital Basel, Basel, Switzerland.

Swiss Medical Weekly
|March 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PRACTICE-HF: Implementation of an updated clinical protocol for acute heart failure.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2026
Same author

Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives.

BMC medicine·2016
Same author

The effect of a nurse-led integrated chronic care approach on quality of life in patients with atrial fibrillation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2013
Same author

Stent thrombosis after coronary stent implantation: a protective effect of high-dose statin therapy?

Cardiology·2013
Same author

NADPH oxidase-dependent oxidative stress in the failing heart: From pathogenic roles to therapeutic approach.

Free radical biology & medicine·2011
Same author

Effect of school based physical activity programme (KISS) on fitness and adiposity in primary schoolchildren: cluster randomised controlled trial.

BMJ (Clinical research ed.)·2010
Same journal

Metamizole-induced agranulocytosis: utilisation trends, pharmacovigilance signals and regulatory risk-minimisation in Switzerland.

Swiss medical weekly·2026
Same journal

Female genital mutilation/cutting and risk of obstetric anal sphincter injury at delivery.

Swiss medical weekly·2026
Same journal

Drug prescription before and after implementation of a CPOE system on the Paediatric Intensive Care Unit: a quality improvement study.

Swiss medical weekly·2026
Same journal

Trends in health- and lifestyle-related aspects in women of childbearing age: analysis of Swiss Health Survey data between 1992 and 2022.

Swiss medical weekly·2026
Same journal

Microplastics in the air and potential health risks - a narrative review.

Swiss medical weekly·2026
Same journal

Potentially inappropriate medication: prevalence, risk of hospitalisation and associated healthcare costs in the general older population of Switzerland.

Swiss medical weekly·2026
See all related articles

Optimizing medical therapy for congestive heart failure (CHF) involves careful titration, accepting certain side effects. Advanced treatments like cardiac resynchronization therapy (CRT) and heart transplantation offer options for persistent symptoms.

Area of Science:

  • Cardiology
  • Heart Failure Management

Background:

  • Congestive heart failure (CHF) remains progressive despite therapeutic advancements.
  • Many patients experience persistent symptoms even with broadened medical therapy.
  • Therapeutic escalation is often limited by perceived, rather than actual, intolerability of side effects.

Purpose of the Study:

  • To review current therapeutic strategies for managing advanced congestive heart failure.
  • To emphasize the importance of adequate medical therapy optimization before considering advanced interventions.
  • To discuss the role of cardiac resynchronization therapy (CRT), implantable defibrillators (ICD), heart transplantation, and assist devices.

Main Methods:

  • Review of existing literature on end-stage congestive heart failure management.

Related Experiment Videos

  • Analysis of acceptable side effect parameters for medical therapy titration (e.g., creatinine increase, hyperkalemia).
  • Evaluation of indications and outcomes for advanced therapies including CRT, ICD, and heart transplantation.

    • Main Results:

    • Acceptable side effects for medical therapy include serum creatinine increase (30-50%) and hyperkalemia (up to 5.5 mmol/l).
    • Cautious and slow uptitration of medical therapy is crucial, especially in severe CHF.
    • Cardiac resynchronization therapy (CRT) significantly improves symptoms and prognosis in selected patients.
    • Combined CRT and ICD therapy may benefit patients by improving functional status.
    • Heart transplantation and assist devices remain options for end-stage CHF, with evolving roles.

    Conclusions:

    • Optimizing medical therapy, including careful titration and acceptance of manageable side effects, is paramount in congestive heart failure (CHF).
    • Advanced therapies such as cardiac resynchronization therapy (CRT), implantable defibrillators (ICD), and heart transplantation offer significant benefits for patients with refractory symptoms.
    • Future therapeutic options for end-stage CHF are expected to expand with ongoing research and device development.